[1] 张有友,刘良,朱江涛,等.常见抗精神病药物心血管毒性的研究进展 [J].中国法医学杂志,2020,35(1):60-63+68.
[2] Alotaibi R,Halbesma N,Bijman LAE,et al.Incidence,characteristics and outcomes of out-of-hospital cardiac arrests in patients with psychiatric illness:A systematic review [J].Resusc Plus,2022,9:100214.
[3] 宋真,夏志春,邝启杰,等.精神科住院患者17例猝死死因分析 [J].中国神经精神疾病杂志,2020,46(2):90-94.
[4] Vohra J.Sudden cardiac death in schizophrenia:A review [J].Heart Lung Circ,2020,29(10):1427-1432.
[5] Zhu J,Hou W,Xu Y,et al.Antipsychotic drugs and sudden cardiac death:A literature review of the challenges in the prediction,management,and future steps [J].Psychiatry Res,2019,281:112598.
[6] Kelly HG,Fay JE,Laverty SG.Thioridazine hydrochloride (mel laril):Its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities [J].Can Med Assoc J,1963,89(11):546-554.
[7] Risgaard B,Waagstein K,Winkel BG,et al.Sudden cardiac death in young adults with previous hospital-based psychiatric inpatient and outpatient treatment:A nationwide cohort study from denmark [J].J Clin Psychiatry,2015,76(9):e1122-1129.
[8] Ray WA,Chung CP,Murray KT,et al.Atypical antipsychotic drugs and the risk of sudden cardiac death [J].N Engl J Med,2009,360(3):225-235.
[9] 刘胤钊,张向荣.抗精神病药物与心源性猝死风险因素 [J].中华行为医学与脑科学杂志,2019,28(6):568-572.
[10] Ruiz Diaz JC,Frenkel D,Aronow WS.The relationship between atypical antipsychotics drugs,qt interval prolongation,and torsades de pointes:Implications for clinical use [J].Expert Opin Drug Saf,2020,19(5):559-564.
[11] He L,Yu Y,Zhang L,et al.A real-world study of risk factors for qtc prolongation in schizophrenia patients receiving atypical antipsychotics [J].J Clin Psychopharmacol,2022,42(1):71-74.
[12] Arteyeva NV.Dispersion of ventricular repolarization:Temporal and spatial[J].World J Cardiol,2020,12(9):437-449.
[13] Redfern WS,Carlsson L,Davis AS,et al.Relationships between preclinical cardiac electrophysiology,clinical qt interval prolongation and torsade de pointes for a broad range of drugs:Evidence for a provisional safety margin in drug development[J].Cardiovasc Res,2003,58(1):32-45.
[14] Cerrone M,Costa S,Delmar M.The genetics of brugada syndrome [J].Annu Rev Genomics Hum Genet,2022,23:255-274.
[15] Brunetti ND,Ieva R,Correale M,et al.Inferior st-elevation acute myocardial infarction or an inferior-lead brugada-like electrocardiogram pattern associated with the use of pregabalin and quetiapine? [J].Am J Ther,2016,23(4):e1057-1059.
[16] Sawyer M,Goodison G,Smith L,et al.Brugada pattern associated with clozapine initiation in a man with schizophrenia [J].Intern Med J,2017,47(7):831-833.
[17] Rastogi A,Viani-Walsh D,Akbari S,et al.Pathogenesis and management of brugada syndrome in schizophrenia:A scoping review [J].Gen Hosp Psychiatry,2020,67:83-91.
[18] Lopez-Medina AI,Chahal CAA,Luzum JA.The genetics of drug-induced qt prolongation:Evaluating the evidence for pharmacodynamic variants [J].Pharmacogenomics,2022,23(9):543-557.
[19] Abbott GW,Sesti F,Splawski I,et al.Mirp1 forms ikr potassium channels with herg and is associated with cardiac arrhythmia[J].Cell,1999,97(2):175-187.
[20] Sicouri S,Antzelevitch C.Sudden cardiac death secondary to antidepressant and antipsychotic drugs [J].Expert Opin Drug Saf,2008,7(2):181-194.
[21] Ono M,Burgess DE,Schroder EA,et al.Long qt syndrome type 2:Emerging strategies for correcting class 2 kcnh2 (herg) mutations and identifying new patients [J].Biomolecules,2020,10(8):1144.
[22] Pérez-Riera AR,Barbosa-Barros R,Daminello Raimundo R,et al.The congenital long qt syndrome type 3:An update[J].Indian Pacing Electrophysiol J,2018,18(1):25-35.
[23] Frommeyer G,Eckardt L.Drug-induced proarrhythmia:Risk factors and electrophysiological mechanisms [J].Nat Rev Cardiol,2016,13(1):36-47.
[24] Tsai CT,Ikematsu K,Sakai S,et al.Expression of bcl2l1,clcf1,il-28ra and pias1 in the mouse heart after single and repeated administration of chlorpromazine [J].Leg Med (Tokyo),2011,13(5):221-225.
[25] Hattori S,Suda A,Kishida I,et al.Association between dysfunction of autonomic nervous system activity and mortality in schizophrenia [J].Compr Psychiatry,2018,86:119-122.
[26] Hinterseer M,Thomsen MB,Beckmann BM,et al.Beat-to-beat variability of qt intervals is increased in patients with drug-induced long-qt syndrome:A case control pilot study[J].Eur Heart J,2008,29(2):185-190.
[27] Fanoe S,Kristensen D,Fink-Jensen A,et al.Risk of arrhythmia induced by psychotropic medications:A proposal for clinical management [J].Eur Heart J,2014,35(20):1306-1315.
[28] Boels D,Mahé J,Olry A,et al.Fatal and life-threatening adrs associated with paliperidone palmitate:An observational study in the french pharmacovigilance database [J].Clin Toxicol (Phila),2021,59(9):786-793.
[29] Sicouri S,Antzelevitch C.Mechanisms underlying the actions of antidepressant and antipsychotic drugs that cause sudden cardiac arrest [J].Arrhythm Electrophysiol Rev,2018,7(3):199-209.
[30] Stock EM,Zeber JE,McNeal CJ,et al.Psychotropic pharmacotherapy associated with qt prolongation among veterans with posttraumatic stress disorder [J].Ann Pharmacother,2018,52(9):838-848.
[31] Trinkley KE,Page RL,Lien H,et al.Qt interval prolongation and the risk of torsades de pointes:Essentials for clinicians [J].Curr Med Res Opin,2013,29(12):1719-1726.
[32] Nasser A,Mitchell AJ.Sudden cardiac death and antipsychotics.Part 2:Monitoring and prevention[J].Advances in Psychiatric Treatment,2006,12(2):100-109.
[33] Daumit GL,Dalcin AT,Dickerson FB,et al.Effect of a comprehensive cardiovascular risk reduction intervention in persons with serious mental illness:A randomized clinical trial [J].JAMA Netw Open,2020,3(6):e207247.
[34] Watanabe J,Fukui N,Suzuki Y,et al.Effect of gwas-identified genetic variants on maximum qt interval in patients with schizophrenia receiving antipsychotic agents:A 24-hour holter ecg study[J].J Clin Psychopharmacol,2017,37(4):452-455.
[35] Kamei S,Sato N,Harayama Y,et al.Molecular analysis of potassium ion channel genes in sudden death cases among patients administered psychotropic drug therapy:Are polymorphisms in lqt genes a potential risk factor? [J].J Hum Genet,2014,59(2):95-99.
[36] Au-Yeung WT,Reinhall PG,Poole JE,et al.Scd-heft:Use of r-r interval statistics for long-term risk stratification for arrhythmic sudden cardiac death [J].Heart Rhythm,2015,12(10):2058-2066.
[37] Martinez-Alanis M,Bojorges-Valdez E,Wessel N,et al.Prediction of sudden cardiac death risk with a support vector machine based on heart rate variability and heartprint indices [J].Sensors (Basel),2020,20(19):5489.
[38] Houshyarifar V,Chehel Amirani M.An approach to predict sudden cardiac death (scd) using time domain and bispectrum features from hrv signal [J].Biomed Mater Eng,2016,27(2-3):275-285.
[39] Ebrahimzadeh E,Pooyan M,Bijar A.A novel approach to predict sudden cardiac death (scd) using nonlinear and time-frequency analyses from hrv signals [J].PLoS One,2014,9(2):e81896.
[40] Vargas-Lopez O,Amezquita-Sanchez JP,De-Santiago-Perez JJ,et al.A new methodology based on emd and nonlinear measurements for sudden cardiac death detection [J].Sensors (Basel),2019,20(1):9.